Researchers performed a retrospective case-control study using data from a large US healthcare network to evaluate the effectiveness of the RSVpreF vaccine in protecting older adults against RSV ...

The estimated effectiveness of the respiratory syncytial virus (RSV) among older US veterans in the 2023-2024 respiratory ...

The U.S. faces a potential 'Quad-emic' with rising cases of flu, COVID, RSV, and norovirus. Older adults, especially those ...

The U.S. is seeing a "quad-demic" as cases of COVID-19, flu, RSV and norovirus spread at the same time. Experts said this is ...

The study, published Jan. 20 in The Lancet Infectious Diseases, found the vaccine to be 78% effective against RSV infection, 79% effective against emergency department and urgent care visits and 80% ...

The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased ...

U.S. surges of COVID-19, influenza, respiratory syncytial virus (RSV) and norovirus have collectively been dubbed a "quad-demic." Here what you can do.

RSV is a common, but highly infectious, respiratory virus that affects the breathing system, particularly in young children ...

The following is a summary of “Respiratory syncytial virus vaccine effectiveness among US veterans, September, 2023 to March, 2024: a target trial emulation study,” published in the January 2025 issue ...

Respiratory illness activity remains high across the country, according to the latest data from the Centers for Disease ...

Most infants born before December were administered nirsevimab, while those whose mothers reached eligible gestational age ...

Bon Secours and Prisma Health are implementing new visitor restrictions as cases of influenza and respiratory illnesses rise ...